Lenti in red: progress in gene therapy for human hemoglobinopathies.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 15467825.
- Also identified by PMC identifier 518672.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hemoglobinopathies are caused by abnormal structure or synthesis of hemoglobin chains and represent serious monogenic disorders. A new study demonstrates that lentiviral vectors can express clinically relevant levels of human transgenic beta-globin in red cells of xenografted mice. While some safety concerns must be addressed, this study is an important step toward potential clinical trials of gene therapy for hemoglobinopathies.
Medical subject headings
- Genetic Therapy
- Hemoglobinopathies